Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xilio Therapeutics (XLO) Treasury Shares (2024 - 2025)

Xilio Therapeutics (XLO) has disclosed Treasury Shares for 2 consecutive years, with $23866.0 as the latest value for Q4 2025.

  • Quarterly Treasury Shares fell 24.99% to $23866.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $23866.0 through Dec 2025, down 24.99% year-over-year, with the annual reading at $23866.0 for FY2025, 24.99% down from the prior year.
  • Treasury Shares hit $23866.0 in Q4 2025 for Xilio Therapeutics, down from $334125.0 in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $481500.0 in Q1 2024 to a low of $23866.0 in Q4 2025.